Current Complaints | Help Center| Subscribe

Recent:

Data for the month ending - Aug, 2026

Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

Trend of Monthly Disposal of Complaints

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

Trend of Annual Disposal of Complaints

Sr. No.	Fin. Year	Received	Resolved*
1	2021-22	1	1
2	2022-23	1	1
3	2023-24	0	0
4	2024-25	0	0
	Grand Total	2	2

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Vanta Bioscience informs about disclosure

Vanta Bioscience Ltd. | Business Support | Miscellaneous | BSE: 540729 | NSE:

24 Nov 2022 Evaluate

Pursuant to Regulation 30 of SEBI (LODR) Regulations, Vanta Bioscience has informed that, an appeal was filed before the National Company Law Appellate Tribunal (‘NCLAT’) against the order of Hon’ble National Company Law Tribunal, Hyderabad (‘NCLT’) dated 27.04.2022 initiating the CIRP process of Vanta Bioscience (the company). The matter was listed on 09.11.2022 and the matter in the said hearing was adjourned to 18.11.2022 with a direction that the Interim Order passed by NCLAT previously shall continue till the next hearing. The matter was listed next on 18.11.2022 and the matter in the said hearing was further adjourned to 24.11.2022 with a direction that the Interim Order passed by NCLAT shall continue till the next hearing. Intimations/disclosures to BSE are being made as and when the same is uploaded on NCLAT Website. The order sheets/case status are also available on the NCLAT website.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sagility	43.12
Prime Focus	301.65
Knowledge RealtyTrt.	112.24
Indegene	594.00
Syngene Internatl.	360.95
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.